We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

38 hedge funds and large institutions have $45.6M invested in Histogen Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $482K | Put options by funds: $178K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less capital invested

Capital invested by funds: $52M → $45.6M (-$6.41M)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

21% less funds holding

Funds holding: 4838 (-10)

50% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 20

Holders
38
Holders Change
-10
Holders Change %
-20.83%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
9
Reduced
11
Closed
20
Calls
$482K
Puts
$178K
Net Calls
+$304K
Net Calls Change
+$304K
Name Holding Trade Value Shares
Change
Change in
Stake
VKH
51
Virtu KCG Holdings
New York
-$86K -53 Closed
RNS
52
Robert N. Shapiro
-$49K -30 Closed
TA
53
Teachers Advisors
New York
-$45K -28 Closed
TRCT
54
Tower Research Capital (TRC)
New York
-$42K -25 Closed
NFA
55
Nationwide Fund Advisors
Ohio
-$39K -24 Closed
AIG
56
American International Group
New York
-$33.2K -20 Closed
Deutsche Bank
57
Deutsche Bank
Germany
-$20K -13 Closed
Citigroup
58
Citigroup
New York
-$8K -5 Closed
LTFS
59
Ladenburg Thalmann Financial Services
Florida
-$2K -1 Closed

HSTO Hedge Fund Activity: Q2 2014 in Review

38 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2014, worth a combined $45.6M — down 12% from $52M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of HSTO and 10 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 9 added.

The largest buyer was Axa, adding an estimated $1.3M. The largest seller was Jennison Associates, exiting entirely with an estimated $6.91M sold.

  • 38 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2014, down from 48 in Q1 2014.
  • Funds reported $45.6M of Histogen Inc. Common Stock stock for Q2 2014, down 12% quarter-over-quarter.
  • 10 funds opened new Histogen Inc. Common Stock positions in Q2 2014 and 20 closed out, a net change of -10 holders.
  • The largest Histogen Inc. Common Stock buyer in Q2 2014 was Axa, an estimated $1.3M added.
  • The largest Histogen Inc. Common Stock seller in Q2 2014 was Jennison Associates, an estimated $6.91M sold.

Based on aggregated 13F filings for Q2 2014.